loader
Please Wait
Applying Filters...

Annual Sales of Glycopyrrolate reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
$ API Ref.Price (USD/KG) : 26,220Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 7Bevespi

02 5Breztri

03 2Lonhala Magnair

04 6Seebri Breezhaler

05 2Ultibro Breezhaler

06 3Ultibro Group

PharmaCompass

01

arrow
FNCE 2024
Not Confirmed

02

Brand Name : Lonhala Magnair

Glycopyrrolate

arrow
FNCE 2024
Not Confirmed

Brand Name : Lonhala Magnair

arrow
FNCE 2024
Not Confirmed

Glycopyrrolate

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 22

2019 Revenue in Millions : 17

Growth (%) : 28

blank

03

Brand Name : Bevespi

Glycopyrrolate

arrow
FNCE 2024
Not Confirmed

04

Brand Name : Ultibro Group

Glycopyrronium Bromide

arrow
FNCE 2024
Not Confirmed

Brand Name : Ultibro Group

arrow
FNCE 2024
Not Confirmed

Glycopyrronium Bromide

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 623

2019 Revenue in Millions : 630

Growth (%) : -1

blank

05

Brand Name : Breztri

Glycopyrronium

arrow
FNCE 2024
Not Confirmed

06

Brand Name : Bevespi

Glycopyrrolate

arrow
FNCE 2024
Not Confirmed

07

Brand Name : Ultibro Group

Glycopyrronium Bromide

arrow
FNCE 2024
Not Confirmed

Brand Name : Ultibro Group

arrow
FNCE 2024
Not Confirmed

Glycopyrronium Bromide

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2021 Revenue in Millions : 584

2020 Revenue in Millions : 623

Growth (%) : -6

blank

08

Brand Name : Breztri

Glycopyrronium

arrow
FNCE 2024
Not Confirmed

09

Brand Name : Ultibro Group

Glycopyrronium

arrow
FNCE 2024
Not Confirmed

Brand Name : Ultibro Group

arrow
FNCE 2024
Not Confirmed

Glycopyrronium

Main Therapeutic Indication : Respiratory Diseases

Currency : USD

2022 Revenue in Millions : 479

2021 Revenue in Millions : 584

Growth (%) : -18

blank

10

Brand Name : Bevespi

Glycopyrrolate

arrow
FNCE 2024
Not Confirmed